Biomaterials and Tissue Engineering Research Center, Shanghai Institute of Ceramics, Chinese Academy of Sciences
中国科学院上海硅酸盐研究所生物材料与组织工程研究中心
Clinically relevant bone regeneration studies in the goat calvaria model and the sheep tibia model
Speaker：Prof. Joachim Kohn
(Rutgers，The State University of New Jersey)
报告时间：2017年9月27日（星期三）下午3:00
报告地点：2号楼607会议室
联系人：常江（52412804）
欢迎广大科研人员和研究生参加！
Joachim Kohn, Ph.D. FBSE
Director, the New Jersey Center for Biomaterials
Board of Governors Professor, Rutgers, the State University of New Jersey
Joachim Kohn, PhD, Board of Governors Professor of Chemistry and Chemical Biology at Rutgers University, is a research entrepreneur, a multi-disciplinary translational scientist, and a national leader in the development of polymeric biomaterials for drug delivery, tissue engineering, and regenerative medicine. In 1997, Kohn founded the New Jersey Center for Biomaterials, which has grown into a collaborative network spanning 25 institutions and 40 laboratories. As a translational scientist, Kohn has 69 issued US Patents on novel biomaterials and seven companies have licensed his technologies. He has raised about $100 Million in research funding at Rutgers and helped four licensees to raise about $200M in private capital.
In 2014, Professor Kohn was inducted into the National Academy of Inventors. He is the recipient of numerous awards and honors, including the prestigious Thomas Alva Edison Patent Award for best patent in New Jersey in the category of medical research, and the Clemson Award from the Society for Biomaterials. He is a Fellow of American Institute of Medical and Biological Engineering and serves as the Chair of the International College of Fellows of Biomaterials Science and Engineering. Since 2008, he is the Director and Principal Investigator of the Rutgers-Cleveland Clinic Consortium of the Armed Forces Institute of Regenerative Medicine, a $60 Million research project funded by the Department of Defense.
Professor Kohn’s scientific expertise ranges from synthetic polymer chemistry and materials science to drug delivery, cell biology, tissue engineering, and regenerative medicine. He pioneered the use of combinatorial and computational methods for the optimization of biomaterials for specific medical applications. He discovered "pseudo-poly(amino acid)s"- a new class of polymers that combine the non-toxicity of individual amino acids with the strength and processability of high-quality engineering plastics. Medical devices using these materials are being developed by several companies, have been approved in the USA and Canada, and have been implanted in about 200,000 patients.
